Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00 | SBC Stock NewsStockTitan·1 day ago, 06:45 AMSBC+2.89%
Zacks Research Has Bearish Estimate for SBC Q3 EarningsMarket Beat·Aug 20 at 05:42 AMSBC+2.89%BLK+0.08%
SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%Market Beat·Aug 19 at 01:01 PMSBC+2.89%
SBC: Leading Japanese aesthetic clinic group achieves rapid global growth and strong financial resultsQuartr·Aug 19 at 07:47 AMSBC+2.89%
SBC Medical Group (NASDAQ:SBC) Stock Rating Upgraded by Wall Street ZenMarket Beat·Aug 15 at 01:07 AMSBC+2.89%BLK+0.08%
SBC Medical Q2 2026 Earnings Call: EBITDA Rises 32% as Growth ReacceleratesTradingKey·Aug 14 at 03:40 AMSBC+2.89%
SBC Medical Group Faces Nasdaq Delisting Risk After Governance Noncompliance, Threatening Liquidity and Investor StabilityTip Ranks·Aug 14 at 01:01 AMSBC+2.89%
SBC Medical | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 49.19 MEarnings Watch·Aug 13 at 05:51 AMSBC+2.89%
SBC Medical FY26 Q2 net income more than quadruples to $11 million; revenue rises 13% to $49 millionPUBT·Aug 13 at 05:31 AMSBC+2.89%
SBC: 2Q 2026 saw 13% revenue growth and 335% net income surge, with strong global expansion plansQuartr·Aug 13 at 05:22 AMSBC+2.89%
